Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen for food craving and binge eating in obese adults
NL-OMON37514Phase 3Withdrawn
- Sponsor
- Slotervaartziekenhuis
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity and Overweight comparing Baclofen with Placebo (2 arms). Primary endpoint: Food-craving score. Planned start Feb 2012; status: withdrawn.
02
Drugs
baclofen
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NL-OMON37514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37514.